Synthesis and anticancer activity of 3a,4-dihydro-3H-indeno[1,2-c]pyrazole- 2-carboxamide analogues

Letters in Drug Design and Discovery

Volumn 9, Issue 9, 2012, Pages 823-827

  Ahsan, Mohamed Jawed ^a,b  

^a Alwar Pharmacy College   (India)

^b NIMS UNIVERSITY   (India)

Author keywords

Antitumor activity; Claisen Schmidt condensation; Molecular docking; Pyrazolines; Tyrosine kinase

Indexed keywords

3 (4 FLUOROPHENYL) N (2,6 DIMETHYLPHENYL) 6,7 DIMETHOXY 3A,4 DIHYDRO 3H INDENO[1,2 C]PYRAZOLE 2 CARBOXAMIDE; 3 SUBSTITUTED N ARYL 6,7 DIMETHOXY 3A,4 DIHYDRO 3H INDENO[1,2 C]PYRAZOLE 2 CARBOXAMIDE ANALOG; AMIDE; ANTINEOPLASTIC AGENT; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CENTRAL NERVOUS SYSTEM TUMOR; COLON CANCER; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROMETRY; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; MELANOMA; MOLECULAR DOCKING; NATIONAL HEALTH ORGANIZATION; NUCLEAR MAGNETIC RESONANCE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 84868033299     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/157018012803307996     Document Type: Article

References (25)

1. WHO, Cancer, World Health Organization, February 2006. http://en.wikipedia.org/wiki/cancer.
2. Aydemir, N.; Bilaloglu, R. Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo. Mutat. Res., 2003, 537, 43-51. (Pubitemid 36556261)
3. Zwick, E.; Bange, J.; Ullrich, A. Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocr. Relat. Cancer, 2001, 8, 161-173. (Pubitemid 32947638)
4. Bhuva, H. A.; Kini, S. G. Synthesis, anticancer activity, and docking of some substituted benzothiazoles as tyrosine kinase inhibitors. J. Mol. Graph. Mod., 2010, 29, 32-37.
5. Mendelsohn, J.; Baselga, J. The EGFR receptor family as targets for cancer therapy. Oncogene, 2000, 19, 6550-6565. (Pubitemid 32197693)
6. Budakoti, A.; Bhat, A. R.; Athar, F.; Azam, A. Syntheses and Evaluation of 3-(3-Bromo phenyl)-5-phenyl-1-(thiazolo[4,5-b]quinoxaline-2-yl)-2-pyrazoline Derivatives. Eur. J. Med. Chem., 2008, 43, 1749-1757.
7. Parmar, S. S.; Pandey, B. R.; Dwivedi, C.; Harbison, R. D. Anticonvulsant activity and monoamine oxidase inhibitory properties of 1,3,5-trisubstituted pyrazolines. J. Pharm. Sci., 1974, 63, 1152-1155.
8. Dawane, B. S.; Konda, S. G.; Mandawad, G. G.; Shaikh, B. M. Poly (ethylene glycol) (PEG 400) as an alternative reaction solvent for the synthesis of some new 1-(4-(4′-chlorophenyl)-2-thiazolyl)-3-aryl-5-(2-butyl-4- chloro-1H-imidazo-5yl)-2-pyrazolines and their in vitro antimicrobial evaluation. Eur. J. Med. Chem., 2010, 45, 387-392.
9. Sharma, P. K.; Kumar, S.; Kumar, P.; Kaushik, P.; Kaushik, D.; Dhingra, Y. Aneja, K. R. Synthesis and biological evaluation of some pyrazolylpyrazolines as anti-inflammatory-antimicrobialagents. Eur. J. Med. Chem., 2010, 45, 2650-2655.
10. Bilgin, A. A.; Palaska, E.; Sunal, R. Studies on the synthesis and antidepressant activity of some 1-thiocarbamoyl-3,5-diphenyl-2-pyrazolines. Drug Res., 1993, 43, 1041-1044. (Pubitemid 23311876)
11. Turan-Zitouni, G.; Chevallet, P.; Kiliç, F. S.; Erol, K. Synthesis of some thiazolyl-pyrazoline derivatives and preliminary investigation of their hypotensive activity. Eur. J. Med. Chem., 2000, 35, 635-641. (Pubitemid 30423195)
12. Mui, M. S.; Siew, B. N.; Buss, A. D.; Crasta, S. C.; Kah, L. G.; Sue, K. L. Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV. Bioorg. Med. Chem. Lett., 2002, 12, 679-699.
13. Manna, F.; Chimenti, F.; Fioravati, R.; Bolasco, A.; Secci, D.; Chimenti, P.; Ferlini, C. Scambia, G. Synthesis of some pyrazole derivatives and preliminary investigation of their affinity bindind to P-glycoprotein. Bioorg. Med. Chem. Lett., 2005, 15, 4632-4635. (Pubitemid 41253909)
14. Ali, M. A.; Shaharyar, M.; Siddique, A. A. Synthesis, Structural Activity Relationship and Anti-Tubercular Activity of Novel Pyrazoline Derivatives. Eur. J. Med. Chem., 2007, 42, 268-275. (Pubitemid 46282221)
15. Ahsan, M. J.; Samy, G. J.; Dutt, K. R.; Agrawal, U. K.; Shankar, B.; Vyas, S.; Kaur, R.; Yadav, G. Design, synthesis and antimycobacterial evaluation of 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-H-indeno[ 1,2-c]pyrazole-2-carboxamide analogues. Bioorg. Med. Chem. Lett., 2011, 21, 4451-53.
16. Ahsan, M. J.; Samy, J. G.; Soni, S.; Jain, N.; Kumar, L.; Sharma, L. K.; Yadav, H.; Saini, L.; Kalyansingh, R. G.; Devenda, N. S.; Prasad, R.; Jain, C. B. Discovery of novel antitubercular 3a,4-dihydro-H-indeno[ 1,2-c]pyrazole-2- carboxamide analogues. Bioorg. Med. Chem. Lett., 2011, 21, 5259-61.
17. Ahsan, M. J.; Samy, G. J.; Khalilullah, H.; Bakht, M. A.; Hassan, M. Z. Synthesis and antimycobacterial evaluation of 3a,4-dihydro-H-indeno[ 1,2-c]pyrazole-2-carboxamide analogues. Eur. J. Med. Chem., 2011, 46, 5694-5697.
18. 4-substituted semicarbazones as novel anticonvulsant agents. Ind. J. Chem., 2010, 49B, 1509-1515
19. Blair, J. A.; Rauh, D.; Kung, C.; Yun, C. H.; Fan, Q.; Rode, H.; Zhang, C.; Eck, M. J.; Weiss, W. A.; Shokat, K. M. Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. Nat. Chem. Bio. 2007, 4, 229-238. (Pubitemid 46440537)
20. http://dtp.nci.nih.gov, (accessed on 22/10/2011)
21. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J.; Boyd, M. Feasibility of a highflux anticancer drug screening using a diverse panel of cultured human tumor cell lines. J. Nat. Cancer Inst., 1991, 83(11), 757-766.
22. Boyd, M. R.; Paull, K. D. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drugdiscovery screen Drug Dev. Res., 1995, 34, 91-109.
23. Shoemaker, R. H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer., 2006, 6, 813-823. (Pubitemid 44450469)
24. www.rcsb.org/pdb, (accessed on 25/10/2011).
25. http://OpenMOPAC.net, (accessed on 25/10/2011).